Target and Its Patented Drug(s)
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T21507 | Target Info | |||
Target Name | Fatty acid-binding protein 5 (FABP5) | ||||
Synonyms | Psoriasis-associated fatty acid-binding protein homolog; PA-FABP; Fatty acid-binding protein, epidermal; Fatty Acid BindingProtein mal1; Epidermal-type fatty acid-binding protein; E-FABP | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | FABP5 | ||||
Biochemical Class | Fatty acid binding protein | ||||
UniProt ID |
Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
---|---|---|---|---|---|
World Intellectual Property Organization (WIPO) | |||||
Patent ID | WO2014146995 | ||||
Title | Urea Derivatives and Their Use As Fatty-Acid Binding Protein (Fabp) Inhibitors. | ||||
Abstract | The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, W, A and B are as described herein, compositions including the compounds and methods of using the compounds. | ||||
Applicant(s) | F. Hoffmann-La Roche Ag | ||||
Representative Drug(s) | D01TJW | Drug Info | IC50 = 3790 nM | Click to Show More | [1] |
2 | D00RDL | Drug Info | IC50 = 6350 nM | [1] | |
3 | D03CJT | Drug Info | IC50 = 13670 nM | [1] | |
4 | D05XAT | Drug Info | IC50 = 19560 nM | [1] | |
5 | D00KCT | Drug Info | IC50 = 23620 nM | [1] | |
United States Patent and Trademark Office (USPTO) | |||||
Patent ID | US2014029723 | ||||
Title | Compositions, formulations and Methods for Treating Ocular Diseases. | ||||
Representative Drug(s) | D0CT9O | Drug Info | IC50 = 20 nM | Click to Show More | [1] |
2 | D01NVM | Drug Info | IC50 = 30 nM | [1] | |
3 | D0SK0L | Drug Info | IC50 = 40 nM | [1] | |
4 | D0R9RK | Drug Info | IC50 = 66 nM | [1] | |
5 | D08IIV | Drug Info | IC50 = 90 nM | [1] | |
6 | D0U2SI | Drug Info | IC50 = 1240 nM | [1] | |
Patent ID | US20130116234 | ||||
Title | Aryl-Quinoline Derivatives. | ||||
Representative Drug(s) | D06JEA | Drug Info | IC50 = 51.2 nM | Click to Show More | [1] |
2 | D0RZ9C | Drug Info | IC50 = 62.3 nM | [1] | |
3 | D07PLJ | Drug Info | IC50 = 63.8 nM | [1] | |
4 | D05WXM | Drug Info | IC50 = 79.8 nM | [1] | |
5 | D01CDK | Drug Info | IC50 = 96.1 nM | [1] | |
6 | D01GOO | Drug Info | IC50 = 182 nM | [1] | |
7 | D0ND3H | Drug Info | IC50 = 183 nM | [1] | |
8 | D08SNH | Drug Info | IC50 = 314 nM | [1] | |
9 | D09VOD | Drug Info | IC50 = 4786 nM | [1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.